跳至主要内容
临床试验/NCT05454878
NCT05454878Unknown不适用

A Cohort Study of Atrial Fibrillation Monitoring on Patients With Lymphoma After Chemotherapy by Applying Wearable Electrocardiogram

Chinese PLA General Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年7月15日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Incidence

研究概览

简要总结

This prospective cohort study is to investigate the incidence of atrial fibrillation after chemotherapy by aplying wearable ECG recoder and the risk factors on patients with newly diagonsed lymphoma

详细描述

This prospective, single-centre, observational cohort study is disigned to enroll 100 newly diagnosed lymphoma patients who met the inclusion and exclusion criteria to monitor the onset of atrial fibrillation and other arrhythmias during chemotherapy by using wearable ECG recorder, and to evaluate the incidence of atrial fibrillation and related risk factors.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years old;
  • Concurrent chemotherapy on patients with new-onset lymphoma: chemotherapy regimens containing anthracyclines;
  • The subject voluntarily signed the informed consent.

排除标准

  • With heart failure, acute stroke or acute coronary syndrome within 3 months before admission
  • With Atrial fibrillation on admission
  • Patient after pacemaker surgery
  • With mental illness or mentally disabled
  • Patients that the investigator considers as unsuitable for this test

结局指标

主要结局

Incidence

时间窗: 1 year after the first course of chemotherapy

Incidence of atrial fibrillation after chemotherapy

次要结局

未报告次要终点

研究者

发起方
Chinese PLA General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yun Dai Chen

professor

Chinese PLA General Hospital

研究点 (1)

Loading locations...

相似试验